SLC39A6 and breast cancer: High cytoplasmic SLC39A6 expression (cut-off, H-score > 160) and high nuclear SLC39A6 expression (cut-off, H-score > 0) were observed in 246/670 (37%) and 285/670 (43%) of the BC cases, respectively.